Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination

Academic Article

• Overview
• Research
• Identity
• Additional Document Info
• View All

Overview

authors

• Tefit, J. N.
• Crabe, S.
• Orlandini, B.
• Nell, H.
• Bendelac, A.
• Deng, S.
• Savage, P. B.
• Teyton, Luc
• Serra, V.

publication date

• October 2014

journal

• Vaccine  Journal

subject areas

• Adjuvants, Immunologic
• Adult
• Animals
• Double-Blind Method
• Galactosylceramides
• Hepatitis B
• Hepatitis B Antibodies
• Hepatitis B Surface Antigens
• Hepatitis B Vaccines
• Humans
• Interferon-gamma
• Macaca fascicularis
• Male
• Mice
• Molecular Structure
• Natural Killer T-Cells

Research

keywords

• ABX196
• Adjuvant
• Glycolipid
• NKT cells
• alpha-GalCer

Identity

PubMed Central ID

• PMC4233108

International Standard Serial Number (ISSN)

• 0264-410X

Digital Object Identifier (DOI)

• 10.1016/j.vaccine.2014.08.070

PubMed ID

• 25218293

Additional Document Info

start page

• 6138

end page

• 6145

volume

• 32

issue

• 46